HOW SUPPLIED
Atracurium Besylate Injection USP, each mL containing 10 mg atracurium besylate, is supplied as follows:
| Unit of Sale | Concentration |
|---|---|
| NDC 0409-1109-01 Carton of 10 Single dose Vials | 50 mg/5 mL (10 mg/mL) |
| NDC 0409-1105-02 *Carton of 10 Multiple dose Vials | 100 mg/10 mL (10 mg/mL) |
Atracurium Besylate Injection should be refrigerated at 2°C to 8°C (36°F to 46°F) to preserve potency. DO NOT FREEZE. Protect from light. Keep vials in carton until time of use.
Upon removal from refrigeration to room temperature storage conditions (25°C/77°F), use Atracurium Besylate Injection within 14 days even if rerefrigerated.
Manufactured by:
Gland Pharma Limited;
Hyderabad 500043, India
Manufactured for:
Hospira, Inc.
Lake Forest, IL 60045 USA
LAB-1214-4.0
Revised: 07/2021